RCOR Renovacor Inc

About RCOR

Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA.
50

Neutral Sentiment

How do you feel about RCOR?

Advertisement|Remove ads.